Details

September 20, 2017


Hospira Issues Voluntary Worldwide Recall for Lots of Hydromorphone HCI Injection, USP, CII, (2 mg/mL) 1 mg/mL Vial, and Levophed® (Norepinephrine Bitartrate Injection, USP), 4 mg/4mL (1 mg/mL) Vial, Due to a Lack of Sterility Assurance



    


Link


Back to Articles